INGN vs RTX · rev $180.2M vs P/E 36, rev $46.78B
Inogen Inc (INGN) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Inogen Inc (INGN) is a medical devices company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported INGN revenue for 2026-06-30 was $180.2M. Net income was -$12.2M. INGN currently screens at market cap $173.5M.
Latest reported RTX revenue for 2026-06-30 was $46.78B. Net income was $4.20B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
INGN currently screens at market cap $173.5M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the INGN and RTX stock pages for the full models.
Not investment advice.